Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin.
作者信息
Wang Chen, McGraw Kathy L, McLemore Amy F, Komrokji Rami, Basiorka Ashley A, Al Ali Najla, Lancet Jeffrey E, Padron Eric, Kosmider Olivier, Fontenay Michaela, Fenaux Pierre, List Alan F, Sallman David A
机构信息
Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
出版信息
Haematologica. 2022 Mar 1;107(3):737-739. doi: 10.3324/haematol.2021.278855.
Abstract
摘要
Zotero 插件